This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Glehen, O. Articles by Rat, P. Search for Related Content PubMed PubMed Citation Articles by Glehen, O. Articles by Rat, P.

Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis From Colorectal Cancer: A Multi-Institutional Study

From the Centre Hospitalo-Universitaire Lyon Sud, Pierre Bénite; Equipe Accueil 3738, Université Claude Bernard Lyon 1, Oullins; Centre Jean Perrin, Clermont-Ferrand; Institut Gustave Roussy, Villejuif; Centre Val d’Aurelle, Montpellier; Centre Paul Papin, Angers; Centre Hospitalo-Universitaire l’Archet 2, Nice; Centre Hospitalier de Bellevue, Saint-Etienne; Centre Hospitalo-Universitaire, Dijon, France; Shizuoka Cancer Centre, Shizuoka, Japan; Tel Aviv Medical Center, Tel Aviv, Israel; Didimotichon General Hospital, Didimotichon, Greece; San Giuseppe Hospital, Empoli, Florence; Regina Elena National Cancer Institute, Roma; Istituto Nazional Tumori, Milano; Hospital Santiago Apostol, Vitoria, Spain; Washington Hospital Center, Washington, DC; Wake Forest University, Baptist Medical Center, Department of General Surgery, Winston-Salem, NC; and SharpHealthCare, San Diego, CA

Address reprint requests to Francois N. Gilly, MD, PhD, Surgical Department, Centre Hospitalo Universitaire Lyon Sud, 69495 Pierre Bénite cedex, France; e-mail: francogi{at}lyon-sud.univ-lyon1.fr

PURPOSE: The three principal studies dedicated to the natural history of peritoneal carcinomatosis (PC) from colorectal cancer consistently showed median survival ranging between 6 and 8 months. New approaches combining cytoreductive surgery and perioperative intraperitoneal chemotherapy suggest improved survival.

PATIENTS AND METHODS: A retrospective multicenter study was performed to evaluate the international experience with this combined treatment and to identify the principal prognostic indicators. All patients had cytoreductive surgery and perioperative intraperitoneal chemotherapy (intraperitoneal chemohyperthermia and/or immediate postoperative intraperitoneal chemotherapy). PC from appendiceal origin was excluded.

RESULTS: The study included 506 patients from 28 institutions operated between May 1987 and December 2002. Their median age was 51 years. The median follow-up was 53 months. The morbidity and mortality rates were 22.9% and 4%, respectively. The overall median survival was 19.2 months. Patients in whom cytoreductive surgery was complete had a median survival of 32.4 months, compared with 8.4 months for patients in whom complete cytoreductive surgery was not possible (P < .001). Positive independent prognostic indicators by multivariate analysis were complete cytoreduction, treatment by a second procedure, limited extent of PC, age less than 65 years, and use of adjuvant chemotherapy. The use of neoadjuvant chemotherapy, lymph node involvement, presence of liver metastasis, and poor histologic differentiation were negative independent prognostic indicators.

CONCLUSION: The therapeutic approach combining cytoreductive surgery with perioperative intraperitoneal chemotherapy achieved long-term survival in a selected group of patients with PC from colorectal origin with acceptable morbidity and mortality. The complete cytoreductive surgery was the most important prognostic indicator.

Presented in part at the American Society of Clinical Oncology Symposium (Merit Award), San Francisco, CA, January 2004.

Authors’ disclosures of potential conflicts of interest are found at the end of this article.

This article has been cited by other articles:

				V. J. Verwaal, S. Bruin, H. Boot, G. van Slooten, and H. van Tinteren 8-Year Follow-up of Randomized Trial: Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy in Patients with Peritoneal Carcinomatosis of Colorectal Cancer Ann. Surg. Oncol., September 1, 2008; 15(9): 2426 - 2432. [Abstract] [Full Text] [PDF]

				N. J. Gusani, S. W. Cho, C. Colovos, S. Seo, J. Franko, S. D. Richard, R. P. Edwards, C. K. Brown, M. P. Holtzman, H. J. Zeh, et al. Aggressive Surgical Management of Peritoneal Carcinomatosis With Low Mortality in a High-Volume Tertiary Cancer Center Ann. Surg. Oncol., March 1, 2008; 15(3): 754 - 763. [Abstract] [Full Text] [PDF]

				R. N. Low, R. M. Barone, J. M. Gurney, and W. D. Muller Mucinous Appendiceal Neoplasms: Preoperative MR Staging and Classification Compared with Surgical and Histopathologic Findings Am. J. Roentgenol., March 1, 2008; 190(3): 656 - 665. [Abstract] [Full Text] [PDF]

				L. Benoit, N. Cheynel, P. Ortega-Deballon, G. Di Giacomo, B. Chauffert, and P. Rat Closed Hyperthermic Intraperitoneal Chemotherapy with Open Abdomen: a Novel Technique to Reduce Exposure of the Surgical Team to Chemotherapy Drugs Ann. Surg. Oncol., February 1, 2008; 15(2): 542 - 546. [Abstract] [Full Text] [PDF]

				E. A. Levine, B. M. Ronnett, P. F. Mansfield, and C. Eng Overview of Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Dissemination of Appendiceal and Colorectal Neoplasms ASCO Educational Book, January 1, 2008; 2008(1): 153 - 159. [Abstract] [Full Text] [PDF]

				T. M. Pawlik, R. D. Schulick, and M. A. Choti Expanding Criteria for Resectability of Colorectal Liver Metastases Oncologist, January 1, 2008; 13(1): 51 - 64. [Abstract] [Full Text] [PDF]

				S. Kusamura, D. Baratti, A. Antonucci, R. Younan, B. Laterza, G. D. Oliva, C. Gavazzi, and M. Deraco Incidence of Postoperative Pancreatic Fistula and Hyperamylasemia after Cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy Ann. Surg. Oncol., December 1, 2007; 14(12): 3443 - 3452. [Abstract] [Full Text] [PDF]

				S. Varghese, M. Burness, H. Xu, T. Beresnev, J. Pingpank, and H. R. Alexander Site-Specific Gene Expression Profiles and Novel Molecular Prognostic Factors in Patients with Lower Gastrointestinal Adenocarcinoma Diffusely Metastatic to Liver or Peritoneum Ann. Surg. Oncol., December 1, 2007; 14(12): 3460 - 3471. [Abstract] [Full Text] [PDF]

				F. Aarts, T. Hendriks, O. C. Boerman, M. J. Koppe, W. J. G. Oyen, and R. P. Bleichrodt A Comparison Between Radioimmunotherapy and Hyperthermic Intraperitoneal Chemotherapy for the Treatment of Peritoneal Carcinomatosis of Colonic Origin in Rats Ann. Surg. Oncol., November 1, 2007; 14(11): 3274 - 3282. [Abstract] [Full Text] [PDF]

				H. Kagaya, J. Kitayama, A. Hidemura, S. Kaisaki, H. Ishigami, J. Takei, T. Kanazawa, and H. Nagawa Metastatic Esophageal Tumor from Cecal Carcinoma Jpn. J. Clin. Oncol., September 4, 2007; (2007) hym078v1. [Abstract] [Full Text] [PDF]

				S. Kusamura, D. Baratti, R. Younan, B. Laterza, G. D. Oliva, P. Costanzo, M. Favaro, C. Gavazzi, F. Grosso, and M. Deraco Impact of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy on Systemic Toxicity Ann. Surg. Oncol., September 1, 2007; 14(9): 2550 - 2558. [Abstract] [Full Text] [PDF]

				L. Bijelic, T. D. Yan, and P. H. Sugarbaker Failure Analysis of Recurrent Disease Following Complete Cytoreduction and Perioperative Intraperitoneal Chemotherapy in Patients with Peritoneal Carcinomatosis from Colorectal Cancer Ann. Surg. Oncol., August 1, 2007; 14(8): 2281 - 2288. [Abstract] [Full Text] [PDF]

				S. J. Lim, J. N. Cormier, B. W. Feig, P. F. Mansfield, R. S. Benjamin, J. R. Griffin, J. L. Chase, P. W. T. Pisters, R. E. Pollock, and K. K. Hunt Toxicity and Outcomes Associated with Surgical Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Patients with Sarcomatosis Ann. Surg. Oncol., August 1, 2007; 14(8): 2309 - 2318. [Abstract] [Full Text] [PDF]

				T. D. Yan, J. Sim, and D. L. Morris Selection of Patients with Colorectal Peritoneal Carcinomatosis for Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy Ann. Surg. Oncol., June 1, 2007; 14(6): 1807 - 1817. [Abstract] [Full Text] [PDF]

				D. Elias, D. Goere, F. Blot, V. Billard, M. Pocard, N. Kohneh-Shahri, and B. Raynard Optimization of Hyperthermic Intraperitoneal Chemotherapy With Oxaliplatin Plus Irinotecan at 43{degrees}C After Compete Cytoreductive Surgery: Mortality and Morbidity in 106 Consecutive Patients Ann. Surg. Oncol., June 1, 2007; 14(6): 1818 - 1824. [Abstract] [Full Text] [PDF]

				T. Yan, L Welch, D Black, and P. Sugarbaker A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma Ann. Onc., May 1, 2007; 18(5): 827 - 834. [Abstract] [Full Text] [PDF]

				D. Elias, E. Benizri, D. DiPietrantonio, P. Menegon, D. Malka, and B. Raynard Comparison of Two Kinds of Intraperitoneal Chemotherapy Following Complete Cytoreductive Surgery of Colorectal Peritoneal Carcinomatosis Ann. Surg. Oncol., February 1, 2007; 14(2): 509 - 514. [Abstract] [Full Text] [PDF]

				J. Esquivel, R. Sticca, P. Sugarbaker, E. Levine, T. D. Yan, R. Alexander, D. Baratti, D. Bartlett, R. Barone, P. Barrios, et al. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement Ann. Surg. Oncol., January 1, 2007; 14(1): 128 - 133. [Full Text] [PDF]

				T. M. Tuttle, Y. Zhang, E. Greeno, and A. Knutsen Toxicity and Quality of Life after Cytoreductive Surgery Plus Hyperthermic Intraperitoneal Chemotherapy Ann. Surg. Oncol., December 1, 2006; 13(12): 1627 - 1632. [Abstract] [Full Text] [PDF]

				M. Links Analogies between reading of medical and religious texts BMJ, November 18, 2006; 333(7577): 1068 - 1070. [Full Text] [PDF]

				T. D. Yan, D. Black, R. Savady, and P. H. Sugarbaker Systematic Review on the Efficacy of Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis From Colorectal Carcinoma J. Clin. Oncol., August 20, 2006; 24(24): 4011 - 4019. [Abstract] [Full Text] [PDF]

				C. Brigand, O. Monneuse, F. Mohamed, A. C. Sayag-Beaujard, S. Isaac, F. N. Gilly, and O. Glehen Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy: Results of a Prospective Study Ann. Surg. Oncol., March 1, 2006; 13(3): 405 - 412. [Abstract] [Full Text] [PDF]

				P. H. Sugarbaker Decreasing the Risk of a Treatment Expands Its Indications Ann. Surg. Oncol., November 1, 2005; 12(11): 868 - 870. [Full Text] [PDF]

				D. Elias, G. Liberale, D. Vernerey, M. Pocard, M. Ducreux, V. Boige, D. Malka, J.-P. Pignon, and P. Lasser Hepatic and Extrahepatic Colorectal Metastases: When Resectable, Their Localization Does Not Matter, But Their Total Number Has a Prognostic Effect Ann. Surg. Oncol., November 1, 2005; 12(11): 900 - 909. [Abstract] [Full Text] [PDF]

				J. Esquivel Multidisciplinary Sequential Therapy for the Treatment of Peritoneal Surface Malignancies of Colorectal Origin: A Plea for Cooperation Between Medical and Surgical Oncologists Ann. Surg. Oncol., November 1, 2005; 12(11): 950 - 951. [Full Text] [PDF]

				J. H. Stewart IV, P. Shen, and E. A. Levine Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Surface Malignancy: Current Status and Future Directions Ann. Surg. Oncol., October 1, 2005; 12(10): 765 - 777. [Abstract] [Full Text] [PDF]